RB1 c.1100A>C ;(p.N367T)

Variant ID: 13-48942713-A-C

NM_000321.2(RB1):c.1100A>C;(p.N367T)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Molecular tracing of prostate cancer lethality.

Oncogene
Wang, Yuanshuo Alice YA; Sfakianos, John J; Tewari, Ashutosh K AK; Cordon-Cardo, Carlos C; Kyprianou, Natasha N
Publication Date: 2020-12

Variant appearance in text: RB1: N367T
PubMed Link: 33046797
Variant Present in the following documents:
  • Main text
View BVdb publication page



Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Medicines (Basel, Switzerland)
Testa, Ugo U; Castelli, Germana G; Pelosi, Elvira E
Publication Date: 2019-07-30

Variant appearance in text: RB1: N367T
PubMed Link: 31366128
Variant Present in the following documents:
  • Main text
  • medicines-06-00082.pdf
View BVdb publication page



Castration-Resistant Prostate Cancer Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents: Opportunities and Challenges.

Cancers
Kita, Yuki Y; Goto, Takayuki T; Akamatsu, Shusuke S; Yamasaki, Toshinari T; Inoue, Takahiro T; Ogawa, Osamu O; Kobayashi, Takashi T
Publication Date: 2018-09-21

Variant appearance in text: RB1: N367T
PubMed Link: 30248934
Variant Present in the following documents:
  • Main text
View BVdb publication page



Genetics and biology of prostate cancer.

Genes & Development
Wang, Guocan G; Zhao, Di D; Spring, Denise J DJ; DePinho, Ronald A RA
Publication Date: 2018-09-01

Variant appearance in text: RB1: N367T
PubMed Link: 30181359
Variant Present in the following documents:
  • Main text
  • 1105.pdf
View BVdb publication page



Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.

Cancers
Crona, Daniel J DJ; Whang, Young E YE
Publication Date: 2017-06-12

Variant appearance in text: RB1: N367T
PubMed Link: 28604629
Variant Present in the following documents:
  • Main text
  • cancers-09-00067.pdf
View BVdb publication page



Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.

International Journal Of Urology : Official Journal Of The Japanese Urological Association
Imamura, Yusuke Y; Sadar, Marianne D MD
Publication Date: 2016-08

Variant appearance in text: RB1: N367T
PubMed Link: 27302572
Variant Present in the following documents:
  • Main text
  • IJU-23-654.pdf
View BVdb publication page



Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer.

Current Urology Reports
Silberstein, John L JL; Taylor, Maritza N MN; Antonarakis, Emmanuel S ES
Publication Date: 2016-04

Variant appearance in text: RB1: N367T
PubMed Link: 26902623
Variant Present in the following documents:
  • Main text
View BVdb publication page



Molecular pathways and targets in prostate cancer.

Oncotarget
Shtivelman, Emma E; Beer, Tomasz M TM; Evans, Christopher P CP
Publication Date: 2014-09-15

Variant appearance in text: RB1: N367T
PubMed Link: 25277175
Variant Present in the following documents:
  • oncotarget-05-7217.pdf
View BVdb publication page